Cardiology Search
Cardiology Cardiology
hypertension%20in%20pregnancy
HYPERTENSION IN PREGNANCY
Hypertension in pregnancy is defined as a systolic blood pressure of ≥140 mmHg or a diastolic blood pressure of ≥90 mmHg, or both, based on at least 2 measurements ≥4 hours apart.
Diagnosis of severe hypertension is made when blood pressure is ≥160/110 mmHg.
Measurement should be repeated after 15 minutes for confirmation of severe hypertension.

Hypertension in Pregnancy References

  1. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007 Jun;28(12):1462-1536. PMID: 17562668
  2. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003 Dec;42(6):1206-1252. http://www.ncbi.nlm.nih.gov/pubmed/?term=14656957. PMID: 14656957
  3. Leeman L, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician. 2008 Jul;78(1):93-100. PMID: 18649616
  4. Magee LA, Helewa M, Moutquin JM, et al; Hypertension Guideline Committee; Strategic Training Initiative in Research in the Reproductive Health Sciences (STIRRHS) Scholars. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can. 2008 Mar;30(3)(Suppl):S1-S48. PMID: 18817592
  5. Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest. 2000 Jul;118(1):214-227. PMID: 10893382
  6. Translating Evidence-based Surveillance and Treatment Strategies (TESS) Advisory Working Group. British Columbia Reproductive Care Program (BCRCP) Obstetric guideline 11. Hypertension in pregnancy. BCRCP. 2006 Jun:1-20. http://www.perinatalservicesbc.ca.
  7. Yoder SR, Thornburg LL, Bisognano JD. Hypertension in pregnancy and women of childbearing age. Am J Med. 2009 Oct;122(10):890-895. doi: 10.1016/j.amjmed.2009.03.036. PMID: 19786154
  8. Gabbe SG, Nielby JR, Simpson JL. Gabbe: Obstetrics normal and problem pregnancies. 4th. New York: Churchill Livingstone, Inc; 2002.
  9. Management of the causes of infertility. In: Stenchever M. Comprehensive Gynecology. 4th. St. Louis: Mosby; 2001.
  10. Larsen PR, Kronenberg HM, et al. Disorders of the female reproductive system. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. William's Textbook of Endocrinology. 10th. Philadelphia: Saunders, an imprint of Elsevier; 2003.
  11. Sibai BM. Hypertension. In: Gabbe SG, Nielby JR, Simpson JL. Gabbe: Obstetrics normal and problem pregnancies. 5th. Philadelphia: Churchill Livingstone, Inc; 2007:901-903.
  12. Pituitary hormones and their hypothalamic releasing factors. In: Parker K, Schimmer B, Hardman J, Limbird L. Goodman and Gilman's The pharmacologic basis of therapeutics. 10th. New York: MacGraw-Hill Medical Publishing Division; 2007.
  13. MedWormhttp://www.medworm.com/rss/index.php/Cardiology/7/http://www.medworm.com/rss/medicalfeeds/specialities/Cardiology.xml
  14. MedWormhttp://www.medworm.com/rss/index.php/OBGYN/29/http://www.medworm.com/rss/medicalfeeds/specialities/OBGYN.xml
  15. Ministry of Health Malaysia, Academy of Medicine of Malaysia & Malaysian Society of Hypertension. Clinical practice guidelines: management of hypertension 3rd ed. Ministry of Health Malaysia Web Site. http://www.moh.gov.my. Feb 2008. Accessed 30 Jul 2013.
  16. National Institutes of Health, National Heart, Lung & Blood Institute, National High Blood Pressure Education Program. Working group report on high blood pressure in pregnancy. http://www.nhlbi.nih.gov. Jul 2002.
  17. MedWorm - Hypertensionhttp://www.medworm.com/rss/medicalfeeds/conditions/Hypertension-News.xml
  18. American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Obstet Gynecol. 2013 Nov;122(5):1122-1131. doi: 10.1097/01.AOG.0000437382.03963.88. PMID: 24150027
  19. Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P, Hypertension Guideline Committee, Society of Obstetricians and Gynaecologists of Canada. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014;36(5):416-438. http://sogc.org. PMID: 24927294
  20. American College of Obstetricians and Gynecologists. Committee opinion no. 623: emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol. 2015 Feb;125(2):521-525. doi: 10.1097/01.AOG.0000460762.59152.d7. Accessed 27 Jan 2015. PMID: 25611642
  21. Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension. 2008 Apr;51(4):960-969. doi: 10.1161/HYPERTENSIONAHA.106.075895. Accessed 27 Jan 2015. PMID: 18259046
  22. Townsend R, O'Brien P, Khalil A. Current best practice in the management of hypertensive disorders in pregnancy. Integr Blood Press Control. 2016 Jul 27;9:79-94. doi: 10.2147/IBPC.S77344. PMID: 27555797
  23. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017 Nov 7:pii: S0735-1097(17)41519-1. doi: 10.1016/j.jacc.2017.11.006. Accessed 16 Nov 2017. PMID: 29146535
  24. Williams B, Mancia G, Spiering W, et al; The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). 2018 ESC/ESH Guidelines for the management of arterial hypertension. ESC website. https://www.escardio.org. 2018. Accessed 25 Aug 2018.
  25. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al; ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018 Sep 7;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340. Accessed 25 Aug 2018. PMID: 30165544
  26. Malaysian Society of Hypertension, Ministry of Health Malaysia, Academy of Medicine of Malaysia. Clinical practice guidelines. Management of hypertension. 5th edition (2018). Academy of Medicine of Malaysia. http://www.acadmed.org.my. 2018. Accessed 07 Dec 2018.
  27. Tay JC, Sule AA, Chew EK, et al. Ministry of Health Clinical Practice Guidelines: Hypertension. Singapore Med J. 2018 Jan;59(1):17-27. doi: 10.11622/smedj.2018007. Accessed 17 Dec 2018. PMID: 29376186
  28. Committee on Obstetric Practice. ACOG Committee Opinion No. 767: Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol. 2019 Feb;133(2):e174-e180. doi: 10.1097/AOG.0000000000003075. PMID: 30575639
  29. Committee on Practice Bulletins - Obstetrics. ACOG Practice Bulletin No. 202: Gestational hypertension and preeclampsia. Obstet Gynecol. 2019 Jan;133(1):e1-e25. doi: 10.1097/AOG.0000000000003018. PMID: 30575675
  30. National Institute for Health and Care Excellence (NICE). Hypertension in pregnancy: diagnosis and management. NICE. https://www.nice.org.uk. 25 Jun 2019.
  31. Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020 Jun;75(6):1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026. Accessed 01 Jun 2020. PMID: 32370572
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
High intakes of egg, fish, dairy products may protect women against CVD
Stephen Padilla, 22 Jun 2020
A dietary pattern (DP) characterized by high intakes of eggs, fish, milk, and other dairy products appears to confer protective benefits against incident cardiovascular disease (CVD) in women, reveals a study.
Finerenone lowers CV risk in patients with CKD, T2D
Elaine Soliven, 12 Dec 2020
Treatment with finerenone led to significantly reduced risk of cardiovascular (CV) events in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D), regardless of their CV disease (CVD) history, according to the FIDELIO-DKD* trial presented at AHA 2020.